Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The International journal on drug policy

• Publication date

  2018-04-01

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1016/j.drugpo.2017.12.013PMID 29367011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

  2018cited by this paper
• Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

  2017cited by this paper
• A systematic review of injecting-related injury and disease among people who inject drugs.

  2017cited by this paper
• Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs.

  2016cited by this paper
• Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

  2016cited by this paper
• Global state of harm reduction 2016.

  2016cited by this paper
• Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.

  2016cited by this paper
• Hepatitis C treatment as prevention: evidence, feasibility, and challenges.

  2016cited by this paper
• The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film.

  2016cited by this paper
• Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility.

  2016cited by this paper
• Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

  2015cited by this paper
• Injecting drug use in prison: prevalence and implications for needle exchange policy.

  2015cited by this paper
• Salvaging a prison needle and syringe program trial in Australia requires leadership and respect for evidence

  2015cited by this paper
• Recommendations for the management of hepatitis C virus infection among people who inject drugs.

  2015cited by this paper
• Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.

  2014cited by this paper
• Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS‐c study

  2014cited by this paper
• Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

  2014cited by this paper
• Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

  2014cited by this paper
• Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment

  2014cited by this paper
• Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities.

  2014cited by this paper
• The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.

  2014cited by this paper
• Recommendations for the management of hepatitis C virus infection among people who inject drugs.

  2013cited by this paper
• Epidemiology and natural history of HCV infection

  2013cited by this paper
• Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta‐analysis

  2013cited by this paper
• Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users.

  2012cited by this paper
• [Evaluation of needle exchange program at Pereiro de Aguiar prison (Ourense, Spain): ten years of experience].

  2012cited by this paper
• High-risk drug-use practices among a large sample of Australian prisoners.

  2012cited by this paper
• Identifying high risk groups for sexually transmitted infections and blood borne viruses upon admission to prison in Western Australia.

  2011cited by this paper
• A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

  2011cited by this paper
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

  2011cited by this paper
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

  2011cited by this paper
• Incidence and risk for acute hepatitis C infection during imprisonment in Australia

  2010cited by this paper
• Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.

  2010cited by this paper
• HIV in people who use drugs 2. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.

  2010cited by this paper
• Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand

  2009cited by this paper
• Interventions to reduce HIV transmission related to injecting drug use in prison.

  2009cited by this paper
• The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico.

  2009cited by this paper
• Hepatitis C virus : epidemiology and immunology

  2009cited by this paper
• The global burden of hepatitis C

  2009cited by this paper
• Pre-incarceration HIV risk behaviours of male and female inmates.

  2009cited by this paper
• Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners.

  2008cited by this paper
• Substance abuse and dependence in prisoners: a systematic review.

  2006cited by this paper
• Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?

  2005cited by this paper
• Taking action to reduce injecting drug‐related harms in prisons: The evidence of effectiveness of prison needle exchange in six countries

  2005cited by this paper
• Drug Use and Its Correlates in an Australian Prisoner Population

  2003cited by this paper
• Prison-based syringe exchange programmes: a review of international research and development.

  2003cited by this paper
• Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.

  2000cited by this paper
• A survey of bloodborne viruses and associated risk behaviours in Greek prisons.

  1998cited by this paper
• Hiv Risk Behaviour of Idus Before, During and After Imprisonment in New South Wales

  1996cited by this paper
• Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin

  year unknowncited by this paper

• Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics

  2025influential citation
• "A never-ending cycle": The structural, economic and social (re)production of blood-borne virus transmission and bacterial infection amongst people who inject drugs in Queensland prisons.

  2025cites this paper
• Costing analysis of a Queensland community corrections hepatitis C screening program

  2025cites this paper
• Drug use among people in prison: A global review of epidemiology, harms and interventions.

  2025cites this paper
• A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study

  2025cites this paper
• Changes in Risk Behaviour Among People With Recent Injecting Drug Use in Oslo 2002-2024.

  2025cites this paper
• Linkage to hepatitis C virus care in a binational cohort study of People who inject drugs on the U.S.-Mexico border.

  2025cites this paper
• Identifying barriers and facilitators to accessing harm reduction services in prisons: A systematic narrative synthesis.

  2025cites this paper
• History of injection drug use in the month preceding incarceration in Iranian prisons

  2025cites this paper
• Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study

  2025cites this paper
• Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.

  2024cites this paper
• Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection

  2024cites this paper
• Cost–benefit analysis of Canada’s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections

  2024cites this paper
• Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers.

  2024cites this paper
• Re-examining mandatory drug testing in Australian prisons.

  2024cites this paper
• Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons.

  2024cites this paper
• Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.

  2024cites this paper
• Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs

  2024influential citation
• Estimating the impact of a police education program on hepatitis C virus (HCV) transmission and disease burden among PWID in Tijuana, Mexico: A dynamic modeling analysis.

  2023cites this paper
• Factors associated with drug use in prison: A systematic review of quantitative and qualitative evidence.

  2023cites this paper
• Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia.

  2023influential citation
• Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study

  2023cites this paper
• HIV policies in Australian prisons: a structured review assessing compliance with international guidelines

  2023cites this paper
• Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.

  2023cites this paper
• Drug use before and during imprisonment: Drivers of continuation.

  2023cites this paper
• Effectiveness of direct‐acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real‐world cohort (REACH‐C)

  2023cites this paper
• Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.

  2022cites this paper
• Evolution of within-host variants of the hepatitis C virus.

  2022cites this paper
• The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience

  2022cites this paper
• Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study.

  2022cites this paper
• Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs

  2022cites this paper
• High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment

  2022cites this paper
• Drug Use Disorders before, during, and after Imprisonment

  2022cites this paper
• Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico.

  2022cites this paper
• Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.

  2022cites this paper
• A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users.

  2021cites this paper
• Long-acting injectable buprenorphine – ‘best practice’ opioid agonist therapy for Australian prisoners

  2021cites this paper
• Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada.

  2021cites this paper
• Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs.

  2021cites this paper
• Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.

  2021cites this paper
• Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons

  2021cites this paper
• Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.

  2021cites this paper
• People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?

  2021cites this paper
• Impact of cumulative incarceration and the post-release period on syringe sharing among people who inject drugs in Tijuana, Mexico: A longitudinal analysis.

  2021cites this paper
• Outpatient opioid use disorder treatment for the ID physician

  2021cites this paper
• Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates.

  2020cites this paper
• Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.

  2020cites this paper
• Violence and hepatitis C transmission in prison—A modified social ecological model

  2020cites this paper
• "A spray bottle and a lollipop stick": An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories.

  2020cites this paper
• Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional study

  2020cites this paper
• The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisoners.

  2020cites this paper
• Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico

  2020cites this paper
• The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use Among an Incarcerated Population in Kentucky, 2008 to 2016

  2020cites this paper
• Anti‐envelope antibody responses in highly exposed seronegative individuals may be associated with protection from HCV infection

  2020cites this paper
• Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.

  2020cites this paper
• Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study

  2020cites this paper
• Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis.

  2020cites this paper
• The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia

  2019cites this paper
• Optimising opioid substitution therapy in the prison environment

  2019cites this paper
• Prisons: ignore them at our peril.

  2019cites this paper
• Gang Involvement and Drug Use Histories Among People Who Inject Drugs in California: A Retrospective Analysis

  2019cites this paper
• Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030

  2018cites this paper
• Update on global epidemiology of viral hepatitis and preventive strategies

  2018cites this paper
• Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis

  year unknowncites this paper